Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4.
about
Inflammation and hypertension: new understandings and potential therapeutic targetsThe growing problem of obesity: mechanisms, consequences, and therapeutic approachesEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressNADPH oxidases in vascular pathology.Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritisRecent highlights of ATVB: diabetes mellitus.Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species productionThe effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.Pharmacological TLR4 Inhibition Protects against Acute and Chronic Fat-Induced Insulin Resistance in RatsAntihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin-Stimulated Muscle Glucose Uptake.Vascular smooth muscle-specific deletion of the leptin receptor attenuates leptin-induced alterations in vascular relaxation.Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.Apocynin attenuates angiotensin II-induced vascular smooth muscle cells osteogenic switching via suppressing extracellular signal-regulated kinase 1/2.Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.Endothelial dysfunction and vascular disease - a 30th anniversary update.Novel Pathophysiological Mechanisms in Hypertension.Antihypertensive Effects of Probiotics.Activation of ERK1/2 by NADPH oxidase-originated reactive oxygen species mediates uric acid-induced mesangial cell proliferation.The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis.Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice.Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension.Effect of silibinin and vitamin E on the ASK1-p38 MAPK pathway in D-galactosamine/lipopolysaccharide induced hepatotoxicity.NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice.The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice.Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertensionGenetic Deletion of NADPH Oxidase 1 Rescues Microvascular Function in Mice With Metabolic Disease.Endothelial Dysfunction in Obesity.Antihypertensive effects of oleuropein-enriched olive leaf extract in spontaneously hypertensive rats.Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats.Suppression of Gut Dysbiosis Reverses Western Diet-Induced Vascular Dysfunction.Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice.NADPH Oxidase Deficiency: A Multisystem Approach.Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome.TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity
P2860
Q26827586-7F093F80-43A3-4B60-99F2-3FC8587C963BQ26851397-65029F19-F1A6-48BD-B302-B3CF689156FAQ27023122-883AEE2F-BF76-4960-B03F-B069BFC5D644Q33632089-6BED438E-7130-4D7F-87B0-EF38781DCEB9Q33740199-F43ED0D6-7A15-4E21-9FC6-D513600E539AQ34088564-601C9952-03F8-4FA8-B617-F572DA7C1961Q35219493-4CF1FC22-74BB-4B1F-AD09-D00878AAB8EDQ35235141-34971CD5-14E2-4347-8B35-6C7DA96F0356Q35702671-288A3934-9AF9-4222-B29B-EBB912922A56Q35740724-A1A176E2-3198-4EE6-AD0F-114A7ABD58EFQ36453194-A5BB85EC-56C1-48EF-97D9-D7E819088629Q36905487-CB5B6FDA-C4EE-4E73-AE35-AEADAD390576Q36976558-66734DD2-18E3-44E5-BFFA-D35C97C6BE20Q37575843-FDE3D1C4-B6C9-44B2-BDB3-F6646B5790C9Q37696347-A1B3F8CA-1F2C-4AA2-A98E-F9F97A782E28Q38184888-1D5BEEBA-AE5A-4B19-969E-E964811AF198Q38680112-ED476EAE-0D5A-456F-969B-F7E2408F4A4EQ39040850-518E9A4B-8971-4503-99A2-1B81558B918DQ39185592-0C72D303-44EA-47F5-841A-825433767C83Q39244162-407E1230-8E1E-4CD4-81FE-49917F418466Q39306993-DAE91A3F-1260-44AC-B20F-7B54DB3C9F38Q40116615-500A782E-88EF-4936-A8F9-DC627C9E03B6Q41630351-24B97A9A-E300-4202-99B0-885AFEF6F039Q42224148-0E7BFC68-3D3C-4591-9EF8-282E8A84DBC0Q42284239-8906B770-9C07-4EC2-B0D4-7D1DDFE1F302Q42452192-C9A38160-661A-412B-BF20-369D53277A90Q42593944-59D87B42-95F0-418A-B1B8-C20CA19193FDQ46339542-0610FF5C-38B5-4179-B6B3-FE4C397B5A21Q46355665-5941951C-D252-445D-B38E-85F8060320B3Q46635785-BFE08CC2-E5E2-48B7-B02B-432C6591C891Q46699315-50B13501-AE36-4A8B-BCD0-1DB4BB825059Q47709267-DCAB2ED8-FA79-47F3-820F-D968114A4734Q48302008-338F63F4-4326-4CBD-8E51-24FF435718F7Q49422978-F0AE7852-9C79-4C71-A7F9-1200845E4EA9Q54336169-4D824BDF-D734-4435-BCCB-84C9E1052904Q58610974-618D1263-0B62-405E-8202-99118D37B4F9
P2860
Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@en
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@nl
type
label
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@en
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@nl
prefLabel
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@en
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@nl
P2093
P921
P1476
Toll-like receptor 4 mutation ...... ADPH oxidase isoforms 1 and 4.
@en
P2093
Chao-Fan Liang
Jacky Tc Liu
P304
P356
10.1161/ATVBAHA.112.301087
P407
P577
2013-02-14T00:00:00Z